Pharmaceutical Packaging Market
Pharmaceutical Packaging Market Forecasts to 2034 - Global Analysis By Product Type (Primary Packaging, Secondary Packaging, and Tertiary Packaging), Material, Dosage Form, Distribution Channel, Technology, End User and By Geography
According to Stratistics MRC, the Global Pharmaceutical Packaging Market is accounted for $170.3 billion in 2026 and is expected to reach $283.9 billion by 2034 growing at a CAGR of 6.6% during the forecast period. Pharmaceutical packaging encompasses primary, secondary, and tertiary solutions designed to protect, contain, and deliver drug products safely to end-users. It includes bottles, blister packs, vials, pre-filled syringes, cartons, and corrugated boxes. Built to ensure product integrity, extend shelf life, and comply with stringent safety regulations, pharmaceutical packaging enables manufacturers to maintain drug efficacy and patient safety. The market is evolving rapidly with smart technologies, anti-counterfeit features, and sustainable materials, thereby contributing significantly to improved healthcare logistics and medication adherence worldwide.
Market Dynamics:
Driver:
Growing demand for biologics and injectable drugs
The rising prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders is driving the development of biologic drugs and injectable therapies. These temperature-sensitive and complex molecules require advanced primary packaging solutions like pre-filled syringes, vials, and cartridges that ensure sterility and stability. Pharmaceutical manufacturers are increasingly investing in high-barrier packaging to protect biologics from moisture, light, and contamination. The shift toward self-administration and home healthcare further boosts demand for user-friendly, ready-to-use injectable packaging. As biologic pipelines expand globally, packaging innovation becomes critical to maintain drug efficacy and patient compliance, thereby accelerating market growth for specialized containment systems.
Restraint:
Fluctuating raw material costs and supply chain volatility
Pharmaceutical packaging heavily relies on plastics, glass, aluminum, and paperboard, all subject to price volatility due to geopolitical tensions, energy costs, and trade policies. Sudden increases in raw material prices compress profit margins for packaging manufacturers and force contract renegotiations with pharma companies. Additionally, supply chain disruptions—such as those experienced during global crises—delay the availability of essential components like rubber stoppers, caps, and specialty films. Smaller packaging converters struggle to secure consistent quality materials, leading to production bottlenecks. These fluctuations create uncertainty in long-term pricing agreements and challenge just-in-time inventory models, ultimately restraining market stability and growth potential.
Opportunity:
Adoption of smart and intelligent packaging technologies
The integration of near-field communication (NFC), radio-frequency identification (RFID), and QR codes into pharmaceutical packaging is revolutionizing drug safety and patient engagement. Smart packaging enables real-time temperature monitoring, tamper evidence, and counterfeit protection while allowing patients to access digital leaflet information and adherence reminders. Regulatory bodies are increasingly supporting serialization and track-and-trace mandates, creating a favorable environment for smart packaging adoption. Emerging markets are witnessing rapid deployment of authentication technologies to combat fake drugs. Innovations in printed electronics and low-cost sensors make intelligent packaging affordable for mass-market drugs. This trend opens new revenue streams for converters and technology providers.
Threat:
Stringent environmental regulations on plastic waste
Governments worldwide are imposing strict regulations on single-use plastics and non-recyclable packaging materials, directly impacting traditional pharmaceutical blister packs, bottles, and plastic films. Extended Producer Responsibility (EPR) laws require manufacturers to manage end-of-life disposal, increasing operational costs. Healthcare facilities and pharmacies face growing pressure to reduce plastic waste from drug packaging. Although bioplastics and recyclable alternatives exist, they often lack the barrier properties required for moisture-sensitive or sterile drugs. Transitioning to sustainable materials without compromising product safety requires significant R&D investment and requalification timelines. Non-compliance risks fines and reputational damage, threatening established packaging lines.
Covid-19 Impact
The pandemic dramatically accelerated pharmaceutical packaging demand, particularly for vaccines, diagnostics, and essential medications. Lockdowns initially disrupted raw material supply chains and glass vial production, leading to shortages. However, packaging manufacturers rapidly scaled up production of vials, pre-filled syringes, and cold-chain compliant shippers. The crisis spurred innovation in temperature-controlled tertiary packaging and aseptic filling lines. Regulatory agencies granted emergency approvals for alternative materials and suppliers. Post-pandemic, the industry has prioritized supply chain diversification, digital serialization, and resilient packaging networks. Investments in automation and near-shoring have increased to prevent future disruptions.
The primary packaging segment is expected to be the largest during the forecast period
The primary packaging segment is expected to account for the largest market share during the forecast period, driven by direct contact with drug products and stringent safety requirements. Bottles, blister packs, vials, ampoules, pre-filled syringes, and cartridges are essential for maintaining sterility, stability, and dosage accuracy. Technological advancements such as high-barrier films and child-resistant closures are enhancing patient safety. Rising biologic and injectable drug volumes are fueling demand for vials and pre-filled syringes.
The smart & intelligent packaging segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the smart and intelligent packaging segment is predicted to witness the highest growth rate, driven by increasing counterfeit drug incidents and regulatory serialization mandates. Integration of RFID, NFC, and temperature sensors enables real-time tracking, tamper evidence, and patient engagement through digital inserts. Pharmaceutical companies are adopting connected packaging to improve supply chain visibility and medication adherence. This segment is becoming pivotal in ensuring drug authenticity and patient safety across developed and emerging economies.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, driven by advanced pharmaceutical manufacturing, high biologic drug consumption, and stringent serialization mandates. The United States leads with major packaging innovators and strong demand for pre-filled syringes and smart packaging. Robust healthcare expenditure and early adoption of anti-counterfeit technologies further support market dominance. Established supply chains and regulatory clarity enable faster commercialization of advanced primary and intelligent packaging solutions across the region.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fuelled by expanding pharmaceutical production in China, India, and Southeast Asia. Increasing generic drug exports, contract packaging activities, and government initiatives promoting local manufacturing drive demand. Rapid healthcare infrastructure modernization and rising chronic disease prevalence boost primary packaging consumption. Cost advantages, technology transfers from global players, and growing adoption of serialization and smart packaging solutions accelerate regional market growth significantly.
Key players in the market
Some of the key players in Pharmaceutical Packaging Market include Amcor plc, Gerresheimer AG, Schott AG, West Pharmaceutical Services, Inc., Becton, Dickinson and Company (BD), AptarGroup, Inc., Berry Global Group, Inc., SGD Pharma, Owens-Illinois, Inc., Nipro Corporation, Datwyler Holding Inc., Catalent, Inc., CCL Industries Inc., Huhtamaki Oyj, and Körber Pharma Packaging AG.
Key Developments:
In September 2025, Amcor plc launched a new line of recyclable high-barrier blister packaging for moisture-sensitive oral solid doses, designed to replace conventional PVC/PVDC laminates. The product received endorsement from the Association of Plastic Recyclers, supporting pharmaceutical companies’ sustainability goals.
In June 2025, Gerresheimer AG announced the expansion of its pre-filled syringe manufacturing facility in Skopje, North Macedonia, to meet growing global demand for biologic drug delivery systems. The expansion includes advanced sterile filling lines and integrated inspection systems.
Product Types Covered:
• Primary Packaging
• Secondary Packaging
• Tertiary Packaging
Materials Covered:
• Plastics & Polymers
• Glass
• Paper & Paperboard
• Aluminum Foil
• Bioplastics & Sustainable Materials
• Other Materials
Dosage Forms Covered:
• Tablets & Capsules
• Liquids & Syrups
• Injectable
• Powders & Granules
• Creams & Ointments
• Aerosols & Sprays
• Transdermal Patches
Distribution Channels Covered:
• Direct Sales
• Distributors & Wholesalers
• E-Commerce & Digital Platforms
Technologies Covered:
• Blister Packaging
• Strip Packaging
• Bottle Filling & Capping
• Sterile Packaging
• Aseptic Packaging
• Smart & Intelligent Packaging
• Anti-Counterfeit Packaging
• Child-Resistant & Senior-Friendly Packaging
End Users Covered:
• Pharmaceutical & Biopharmaceutical Manufacturers
• Contract Manufacturing Organizations (CMOs)
• Contract Packaging Organizations (CPOs)
• Retail & Hospital Pharmacies
• Clinical Research Laboratories
Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 Global Pharmaceutical Packaging Market, By Product Type
5.1 Primary Packaging
5.1.1 Bottles
5.1.2 Blister Packs
5.1.3 Vials & Ampoules
5.1.4 Pre-Filled Syringes
5.1.5 Cartridges
5.1.6 Sachets & Strip Packs
5.2 Secondary Packaging
5.2.1 Cartons & Boxes
5.2.2 Labels & Inserts
5.2.3 Display Boxes
5.3 Tertiary Packaging
5.3.1 Corrugated Boxes
5.3.2 Pallets & Shrink Wraps
5.3.3 Drums & Bulk Containers
6 Global Pharmaceutical Packaging Market, By Material
6.1 Plastics & Polymers
6.2 Glass
6.3 Paper & Paperboard
6.4 Aluminum Foil
6.5 Bioplastics & Sustainable Materials
6.6 Other Materials
7 Global Pharmaceutical Packaging Market, By Dosage Form
7.1 Tablets & Capsules
7.2 Liquids & Syrups
7.3 Injectable
7.4 Powders & Granules
7.5 Creams & Ointments
7.6 Aerosols & Sprays
7.7 Transdermal Patches
8 Global Pharmaceutical Packaging Market, By Distribution Channel
8.1 Direct Sales
8.2 Distributors & Wholesalers
8.3 E-Commerce & Digital Platforms
9 Global Pharmaceutical Packaging Market, By Technology
9.1 Blister Packaging
9.2 Strip Packaging
9.3 Bottle Filling & Capping
9.4 Sterile Packaging
9.5 Aseptic Packaging
9.6 Smart & Intelligent Packaging
9.7 Anti-Counterfeit Packaging
9.8 Child-Resistant & Senior-Friendly Packaging
10 Global Pharmaceutical Packaging Market, By End User
10.1 Pharmaceutical & Biopharmaceutical Manufacturers
10.2 Contract Manufacturing Organizations (CMOs)
10.3 Contract Packaging Organizations (CPOs)
10.4 Retail & Hospital Pharmacies
10.5 Clinical Research Laboratories
11 Global Pharmaceutical Packaging Market, By Geography
11.1 North America
11.1.1 United States
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 United Kingdom
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Netherlands
11.2.7 Belgium
11.2.8 Sweden
11.2.9 Switzerland
11.2.10 Poland
11.2.11 Rest of Europe
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Australia
11.3.6 Indonesia
11.3.7 Thailand
11.3.8 Malaysia
11.3.9 Singapore
11.3.10 Vietnam
11.3.11 Rest of Asia Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Colombia
11.4.4 Chile
11.4.5 Peru
11.4.6 Rest of South America
11.5 Rest of the World (RoW)
11.5.1 Middle East
11.5.1.1 Saudi Arabia
11.5.1.2 United Arab Emirates
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 Rest of Middle East
11.5.2 Africa
11.5.2.1 South Africa
11.5.2.2 Egypt
11.5.2.3 Morocco
11.5.2.4 Rest of Africa
12 Strategic Market Intelligence
12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment
13 Industry Developments and Strategic Initiatives
13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives
14 Company Profiles
14.1 Amcor plc
14.2 Gerresheimer AG
14.3 Schott AG
14.4 West Pharmaceutical Services, Inc.
14.5 Becton, Dickinson and Company (BD)
14.6 AptarGroup, Inc.
14.7 Berry Global Group, Inc.
14.8 SGD Pharma
14.9 Owens-Illinois, Inc.
14.10 Nipro Corporation
14.11 Datwyler Holding Inc.
14.12 Catalent, Inc.
14.13 CCL Industries Inc.
14.14 Huhtamaki Oyj
14.15 Körber Pharma Packaging AG
List of Tables
1 Global Pharmaceutical Packaging Market Outlook, By Region (2023-2034) ($MN)
2 Global Pharmaceutical Packaging Market Outlook, By Product Type (2023-2034) ($MN)
3 Global Pharmaceutical Packaging Market Outlook, By Primary Packaging (2023-2034) ($MN)
4 Global Pharmaceutical Packaging Market Outlook, By Bottles (2023-2034) ($MN)
5 Global Pharmaceutical Packaging Market Outlook, By Blister Packs (2023-2034) ($MN)
6 Global Pharmaceutical Packaging Market Outlook, By Vials & Ampoules (2023-2034) ($MN)
7 Global Pharmaceutical Packaging Market Outlook, By Pre-Filled Syringes (2023-2034) ($MN)
8 Global Pharmaceutical Packaging Market Outlook, By Cartridges (2023-2034) ($MN)
9 Global Pharmaceutical Packaging Market Outlook, By Sachets & Strip Packs (2023-2034) ($MN)
10 Global Pharmaceutical Packaging Market Outlook, By Secondary Packaging (2023-2034) ($MN)
11 Global Pharmaceutical Packaging Market Outlook, By Cartons & Boxes (2023-2034) ($MN)
12 Global Pharmaceutical Packaging Market Outlook, By Labels & Inserts (2023-2034) ($MN)
13 Global Pharmaceutical Packaging Market Outlook, By Display Boxes (2023-2034) ($MN)
14 Global Pharmaceutical Packaging Market Outlook, By Tertiary Packaging (2023-2034) ($MN)
15 Global Pharmaceutical Packaging Market Outlook, By Corrugated Boxes (2023-2034) ($MN)
16 Global Pharmaceutical Packaging Market Outlook, By Pallets & Shrink Wraps (2023-2034) ($MN)
17 Global Pharmaceutical Packaging Market Outlook, By Drums & Bulk Containers (2023-2034) ($MN)
18 Global Pharmaceutical Packaging Market Outlook, By Material (2023-2034) ($MN)
19 Global Pharmaceutical Packaging Market Outlook, By Plastics & Polymers (2023-2034) ($MN)
20 Global Pharmaceutical Packaging Market Outlook, By Glass (2023-2034) ($MN)
21 Global Pharmaceutical Packaging Market Outlook, By Paper & Paperboard (2023-2034) ($MN)
22 Global Pharmaceutical Packaging Market Outlook, By Aluminum Foil (2023-2034) ($MN)
23 Global Pharmaceutical Packaging Market Outlook, By Bioplastics & Sustainable Materials (2023-2034) ($MN)
24 Global Pharmaceutical Packaging Market Outlook, By Other Materials (2023-2034) ($MN)
25 Global Pharmaceutical Packaging Market Outlook, By Dosage Form (2023-2034) ($MN)
26 Global Pharmaceutical Packaging Market Outlook, By Tablets & Capsules (2023-2034) ($MN)
27 Global Pharmaceutical Packaging Market Outlook, By Liquids & Syrups (2023-2034) ($MN)
28 Global Pharmaceutical Packaging Market Outlook, By Injectable (2023-2034) ($MN)
29 Global Pharmaceutical Packaging Market Outlook, By Powders & Granules (2023-2034) ($MN)
30 Global Pharmaceutical Packaging Market Outlook, By Creams & Ointments (2023-2034) ($MN)
31 Global Pharmaceutical Packaging Market Outlook, By Aerosols & Sprays (2023-2034) ($MN)
32 Global Pharmaceutical Packaging Market Outlook, By Transdermal Patches (2023-2034) ($MN)
33 Global Pharmaceutical Packaging Market Outlook, By Distribution Channel (2023-2034) ($MN)
34 Global Pharmaceutical Packaging Market Outlook, By Direct Sales (2023-2034) ($MN)
35 Global Pharmaceutical Packaging Market Outlook, By Distributors & Wholesalers (2023-2034) ($MN)
36 Global Pharmaceutical Packaging Market Outlook, By E-Commerce & Digital Platforms (2023-2034) ($MN)
37 Global Pharmaceutical Packaging Market Outlook, By Technology (2023-2034) ($MN)
38 Global Pharmaceutical Packaging Market Outlook, By Blister Packaging (2023-2034) ($MN)
39 Global Pharmaceutical Packaging Market Outlook, By Strip Packaging (2023-2034) ($MN)
40 Global Pharmaceutical Packaging Market Outlook, By Bottle Filling & Capping (2023-2034) ($MN)
41 Global Pharmaceutical Packaging Market Outlook, By Sterile Packaging (2023-2034) ($MN)
42 Global Pharmaceutical Packaging Market Outlook, By Aseptic Packaging (2023-2034) ($MN)
43 Global Pharmaceutical Packaging Market Outlook, By Smart & Intelligent Packaging (2023-2034) ($MN)
44 Global Pharmaceutical Packaging Market Outlook, By Anti-Counterfeit Packaging (2023-2034) ($MN)
45 Global Pharmaceutical Packaging Market Outlook, By Child-Resistant & Senior-Friendly Packaging (2023-2034) ($MN)
46 Global Pharmaceutical Packaging Market Outlook, By End User (2023-2034) ($MN)
47 Global Pharmaceutical Packaging Market Outlook, By Pharmaceutical & Biopharmaceutical Manufacturers (2023-2034) ($MN)
48 Global Pharmaceutical Packaging Market Outlook, By Contract Manufacturing Organizations (CMOs) (2023-2034) ($MN)
49 Global Pharmaceutical Packaging Market Outlook, By Contract Packaging Organizations (CPOs) (2023-2034) ($MN)
50 Global Pharmaceutical Packaging Market Outlook, By Retail & Hospital Pharmacies (2023-2034) ($MN)
51 Global Pharmaceutical Packaging Market Outlook, By Clinical Research Laboratories (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
